But even with the best available Patient-Reported Outcomes surveys and supporting documentation, pharmaceutical and biotechnology clients benefit from QualityMetric’s Outcomes Insight™ Consulting  services for:

• Developing or choosing patient-reported outcomes measures for use in all phases of drug/device development and testing;
• Designing clinical trials, data collection protocols and analytic plans;

• Tracking and monitoring the quality of patient-reported outcomes data with proven Data Quality Evaluation and  Missing Data Estimation tools;

• Interpreting treatment effects against published and proprietary benchmarking databases;

• Tracking and building on published references of previous experiences with SF tools in key therapeutic areas using the SF Literature Review;

• Providing post-hoc analysis of completed trials to optimize strategies for future efforts;

• Preparing abstracts, presentations, and manuscripts reporting results for publication in leading peer-reviewed journals and presentation to internal and external stakeholders.

With over three decades of experience in the development and application of generic and disease-specific Patient-Reported Outcomes surveys, QualityMetric’s Outcomes Insight™ Consulting can be a determining factor for companies seeking FDA approval.

For information, please contact:

QualityMetric Scientists Publish Series of Peer-reviewed Articles

We would also like to share news of the publication of a series of peer-reviewed articles documenting the success of our leading-edge approach to the development of Patient-Reported Outcome measures. Nine peer-reviewed articles authored by QualityMetric scientists present the development and validation of the DYNHA® Headache Impact Test™ and the Headache Impact Survey™. The articles appear in the latest issue of “Quality of Life Research”, and cover topics ranging from computer adaptive technology for survey administration to usefulness of the SF-8 Health Survey™ in headache impact assessment.  They contain detailed analysis and results from our extensive and internationally recognized research in headache impact assessment conducted with partners from GlaxoSmithKline.

World Renowned Consulting Team Adds to Scientific Capability

We also thought you’d be interested in knowing that QualityMetric has recently added three experienced and respected scientists, enhancing our already-strong consulting capability:

• Jakob B. Bjorner, MD, PhD, joins QualityMetric’s Executive and Science Teams as the Deputy-Chief Science Officer. Jakob joins us from Denmark, where he recently served as the Senior Researcher for the National Institute of Occupational Health
• Carolyn E. Schwartz, ScD, with a doctorate from the Harvard School of Public Health, is currently a senior scientist at QualityMetric, the Director of Behavioral Science Research at Health Assessment Lab, and holds a faculty appointment as Associate Professor of Medicine at the University of Massachusetts Medical School, Worcester, MA
• Renee N. Saris-Baglama, PhD, a former professor of psychology at the University of Rhode Island teaching undergraduate courses in statistics and research methods, also taught at Ball State University in Indiana, Moorehead State University in Kentucky, and has served as a Research Consultant for the Community Research Services Team at Brown University

I would welcome the opportunity to speak with you about how QualityMetric might support your efforts to incorporate Patient-Reported Outcomes measures in clinical trials and other studies.

Please feel free to contact me: